Literature DB >> 16449707

Brain white-matter hyperintensities and treatment outcome in major depressive disorder.

Dan V Iosifescu1, Perry F Renshaw, In Kyoon Lyoo, Ho Kyu Lee, Roy H Perlis, George I Papakostas, Andrew A Nierenberg, Maurizio Fava.   

Abstract

BACKGROUND: An increased incidence of brain white-matter hyperintensities has been described in major depressive disorder, butthe impact of such hyperintensities on treatment outcome is still controversial. AIMS: To investigate the relationship of brain white-matter hyperintensities with cardiovascular risk factors and with treatment outcome in younger people with major depressive disorder.
METHOD: We assessed brain white-matter hyperintensities and cardiovascular risk factors in 84 people with major depressive disorder prior to initiating antidepressant treatment. We also assessed hyperintensities in 35 matched controls.
RESULTS: We found no significant difference in the prevalence of white-matter hyperintensities between the depression and the control groups. Left-hemisphere subcortical hyperintensities correlated with lower rates of treatment response. We found no correlation between global hyperintensity measures and clinical outcome. Brain white-matter hyperintensities correlated with hypertension and age and withtotal cardiovascular risk score.
CONCLUSIONS: Subcortical white-matter hyperintensities in the left hemisphere (but notin other brain areas) maybe associated with poor response to antidepressant treatment in major depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449707     DOI: 10.1192/bjp.188.2.180

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  20 in total

Review 1.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 2.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

3.  Depression and coronary artery disease.

Authors: 
Journal:  Psychiatry (Edgmont)       Date:  2009-06

4.  Clinical applications of neuroimaging for treating depressive disorders.

Authors:  Steven D Targum; Dan V Iosifescu
Journal:  Psychiatry (Edgmont)       Date:  2009-06

5.  White matter hyperintensities and their association with suicidality in major affective disorders: a meta-analysis of magnetic resonance imaging studies.

Authors:  Maria Conceição Grangeon; Camila Seixas; Lucas C Quarantini; Angela Miranda-Scippa; Maurizio Pompili; David C Steffens; Amy Wenzel; Acioly L T Lacerda; Irismar Reis de Oliveira
Journal:  CNS Spectr       Date:  2010-06       Impact factor: 3.790

6.  Effects of white matter integrity and brain volumes on late life depression in the Framingham Heart Study.

Authors:  Wei Qiao Qiu; Jayandra J Himali; Philip A Wolf; D Charles DeCarli; Alexa Beiser; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2016-04-05       Impact factor: 3.485

7.  Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study.

Authors:  Wouter S Hoogenboom; Roy H Perlis; Jordan W Smoller; Qing Zeng-Treitler; Vivian S Gainer; Shawn N Murphy; Susanne E Churchill; Isaac S Kohane; Martha E Shenton; Dan V Iosifescu
Journal:  Psychiatry Res       Date:  2012-11-11       Impact factor: 3.222

Review 8.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

Review 9.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

10.  White-matter hyperintensities in first-episode psychosis.

Authors:  Marcus V Zanetti; Maristela S Schaufelberger; Cláudio C de Castro; Paulo R Menezes; Márcia Scazufca; Philip K McGuire; Robin M Murray; Geraldo F Busatto
Journal:  Br J Psychiatry       Date:  2008-07       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.